The globalexotic pets marketsize was estimated at USD 1.75 billion in 2025 and is projected to reach USD 3.21 billion by 2033, growing at a CAGR of 8.1% from 2026 to 2033. The market is advancing due to the expansion of specialized veterinary and pet care services, increasing exotic pet ownership and expenditure, rising adoption of exotic pet insurance, and expansion of product availability. Growing consumer interest in unique companion animals and increasing spending on pet healthcare and wellness are also contributing significantly to market growth worldwide.
Exotic pets include animals such as reptiles, birds, amphibians, small mammals, and other non-traditional companion animals that require specialized care and healthcare services. The market is witnessing steady growth as pet owners increasingly seek advanced healthcare products, nutritional solutions, and veterinary treatments tailored specifically for exotic species. Rising awareness regarding animal health and increasing availability of specialized veterinary professionals are supporting the expansion of the exotic pets market globally.
Key Market Trends Insights
- North America exotic pets market held the largest revenue share of 50.02% in 2025. The regions dominance is supported by high pet ownership rates, increasing spending on companion animal healthcare, and strong availability of specialized veterinary services. Consumers across North America are increasingly adopting exotic pets and investing in premium healthcare products, insurance plans, and wellness services for their animals. In addition, growing awareness regarding preventive veterinary care and rising demand for specialized pet treatment solutions are contributing to market growth across the region.
- The U.S. dominated the North America region with the largest revenue share in 2025. The country continues to witness increasing ownership of reptiles, birds, and small mammals as companion animals. Rising disposable incomes, growing consumer interest in unique pets, and expanding availability of specialized pet healthcare services are supporting market growth in the U.S. Furthermore, increasing adoption of pet insurance and growing investments in veterinary infrastructure are contributing to higher demand for exotic pet products and treatments throughout the country.
- By product, the pharmaceuticals segment held the largest share of 69.51% of the market in 2025. Pharmaceutical products for exotic pets include antibiotics, anti-inflammatory drugs, vaccines, antiparasitic medications, and nutritional supplements designed specifically for non-traditional companion animals. The large market share of this segment is attributed to increasing demand for disease prevention, infection treatment, and routine healthcare management for exotic pets. Rising veterinary visits and growing focus on animal health maintenance are further supporting the growth of the pharmaceuticals segment.
- By animal, the small mammals segment held the largest market share in 2025. Small mammals such as rabbits, guinea pigs, ferrets, hamsters, and hedgehogs are increasingly being adopted as companion animals due to their manageable size and suitability for indoor living environments. Rising urbanization and growing preference for smaller pets among consumers are contributing significantly to the growth of this segment. Increasing demand for specialized nutrition, healthcare products, and veterinary services for small mammals is also supporting market expansion.
- By route of administration, the oral segment held the largest market share in 2025. Oral medications and supplements are widely preferred for exotic pets because they offer ease of administration, convenience, and improved compliance for pet owners and veterinarians. Oral treatments are commonly used for infection management, nutritional supplementation, pain relief, and chronic disease treatment across various exotic animal species. The increasing availability of flavored formulations and easy-to-administer dosage forms is further contributing to the growth of the oral segment within the market.
Looking for more specific insights? Customize this report to suite your business needs
Key Companies Market Share Insights
The global exotic pet market is expanding due to rising interest in unique companion animals, increased urbanization, and greater access to specialized care products. Key players such as Mazuri, Vetafarm, Versele Laga, Zoetis, Merck, AdvaCare Pharma, and VETARK are driving innovation in nutrition, health, and habitat enrichment. Growing online retail, education, and awareness of ethical sourcing are boosting demand for high-quality, species-specific products. With improving veterinary expertise and regional market expansion, the sector is poised for steady growth globally.
Key Exotic Pets Companies:
- AdvaCare Pharma
- VETARK (Candioli Srl)
- Vetafarm
- Mazuri
- Versele Laga
- CROCdoc (a sister company of The Birdcare Company)
- Zoetis Inc.
- Merck Co., Inc
- Vetnil
- Pet King Brands
Grand View Research offers
- Focused market intelligence reports on specific geographies or high-growth segments.
- Extended forecast timelines for long-term planning.
- Competitor Benchmarking and Supply Chain Analysis
- Inclusion of regulatory and policy assessments.
- Inclusion of custom data models, KPIs, or applications unique to your business
- Specific high-impact Data Decks and Tables to support effective decision making
- And much more
Looking for a report customized to your requirements?Explore our Custom Research Offering
